United States News All stories

The Coca-Cola Company (NYSE:KO) resumed most Fairlife milk production after a ransomware attack disrupted operations at four U.S. facilities.

Apple (NASDAQ:AAPL) reclaimed the title of the world’s most valuable public company on Monday as its market capitalisation reached about $4.94 trillion after shares rose more than 1%.

SpaceX (NASDAQ:SPCX) shares fell to a new all-time low of $109.53 on Monday despite the company completing a successful Starship test flight days earlier.

Oil prices declined and U.S. stocks gained on Monday after a pause in fighting between the United States and Iran increased expectations that diplomatic efforts could continue.

MapLight Therapeutics NASDAQ:MPLT) reported positive topline results from its Phase 2 ZEPHYR trial evaluating ML-007C-MA in adults with acute exacerbation of schizophrenia.

Neumora Therapeutics (NASDAQ:NMRA) reported favorable results from a repeat 162-animal toxicology study for its NMRA-215 obesity program.

VERAXA Biotech (NASDAQ:VRXA) announced that its VXA-222 bispecific antibody-drug conjugate programme has reached a technical milestone and advanced into the next phase of its collaboration with OmniAb (NASDAQ:OABI).

Yarrow Bioscience (NASDAQ:YARW) completed its merger with VYNE Therapeutics and closed previously announced private financings totaling approximately $200 million to support its biotechnology development programme.

Lakeland Financial Corporation (NASDAQ:LKFN) reported record second-quarter 2026 net income of $28.4 million, or $1.13 per diluted share, compared with $27 million, or $1.04 per share, in the second quarter of 2025.

Nuwellis (NASDAQ:NUWE), a medical technology company focused on cardiorenal solutions, reported preliminary second-quarter 2026 revenue growth of 14% year over year and first-half 2026 revenue growth of 20%.

Diana (NYSE:DSX) terminated its tender offer for Genco (NYSE:GNK) to force negotiations regarding its $27.34 per share acquisition proposal.

Sierra Bancorp (NASDAQ:BSRR), parent company of Bank of the Sierra, reported second-quarter 2026 net income of $9.9 million, or $0.77 per diluted share, compared with $10.6 million, or $0.78 per share, in the second quarter of 2025.

Citizens Community Bancorp (NASDAQ:CZWI) reported second-quarter 2026 net income of $1.1 million following higher credit loss provisions.

Bank of Marin Bancorp (NASDAQ:BMRC) reported second-quarter 2026 net income of $9.2 million, or $0.58 per share, compared with a loss in the same period last year.

Hope Bancorp (NASDAQ:HOPE), the holding company of Bank of Hope, reported second-quarter 2026 net income of $33 million, or $0.26 per diluted common share, compared with a net loss of $24.8 million, or $0.19 per share, in the second quarter of 2025.

Luxfer Holdings (NYSE:LXFR) has entered into a definitive agreement to be acquired by affiliates of Wynnchurch Capital in an all-cash transaction that will pay shareholders $17.37 per ordinary share.

Northeast Bank (NASDAQ:NBN) reported a fourth-quarter net income of $34.3 million for the period ended June 30, 2026.

Ponce Financial Group (NASDAQ:PDLB) reported second-quarter common-stockholder net income of $8.2 million, up 41%, with diluted EPS of $0.35.

TransDigm Group (NYSE:TDG) agreed to acquire Prince & Izant for approximately $1.066 billion in cash, including certain tax benefits.

Honeywell Technologies (NASDAQ:HON) completed its all-cash WWS sale to American Industrial Partners, with financial terms undisclosed.

Costamare (NYSE:CMRE) reported second-quarter net income from continuing operations of $83.9 million and liquidity of $423 million.

Gossamer Bio (NASDAQ:GOSS) has announced a series of strategic and regulatory updates, highlighted by plans to submit a New Drug Application (NDA) for its lead candidate, seralutinib, in September 2026.

Alliance Resource Partners (NASDAQ:ARLP) reported second-quarter revenue of $551.6 million, up 0.7%, while net income increased 33.9% to $79.6 million.

Biohaven (NYSE:BHVN) and Yale University announced a favorable verdict from a federal jury in the U.S. District Court for the District of Delaware regarding their ongoing litigation against Avilar Therapeutics and RA Capital.